ArticleAnnals of translational medicine2018

Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.

Anastasios Tentolouris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.